Cepheid 

(Public, NASDAQ:CPHD)   Watch this stock   
Find more results for CPHD
Dec 2, 2009
Piper Jaffray Healthcare Conference - 1:30PM EST - Add to calendar
Dec 1, 2009
Nasdaq Conference - 5:45AM EST - Add to calendar
Nov 12, 2009
Credit Suisse Healthcare Conference - Webcast
Oct 28, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 28, 2009
Q3 2009 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference - Webcast
Sep 16, 2009
Think Equity Growth Conference - Webcast
Sep 10, 2009
Robert W. Baird & Co., Inc. Health Care Conference - Webcast
Sep 9, 2009
Thomas Weisel Partners Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -9.22% -13.20%
Operating margin -10.09% -13.94%
EBITD margin - 0.24%
Return on average assets -8.17% -12.91%
Return on average equity -12.26% -17.68%
Employees 547 -

Address

904 Caribbean Drive
Sunnyvale, CA 94089
United States - Map
+1-408-5414191 (Phone)
+1-408-5414192 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Cepheid discussed on blogs

Ranking 1500+ Small Cap Stocks by Year-to-Date Performance ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Cepheid discussions

  View all discussions »

Description

Cepheid is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for testing in the clinical market, as well as for application in the biothreat and industrial markets. The Company’s systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company’s two principal systems are the GeneXpert and SmartCycler systems. The GeneXpert system integrates sample preparation in addition to deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors’ offices. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample.

Officers and directors

Thomas L. Gutshall
Chairman of the Board
Age: 71
Bio & Compensation - Reuters
John L. Bishop
Chief Executive Officer, Director
Age: 64
Bio & Compensation - Reuters
Andrew D. Miller
Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation - Reuters
Humberto Reyes
Chief Operating Officer, Executive Vice President
Age: 63
Bio & Compensation - Reuters
David H. Persing M.D, Ph.D.
Executive Vice President, Chief Medical and Technology Officer, Director
Age: 53
Bio & Compensation - Reuters
Nicolaas Arnold
Executive Vice President - Worldwide Commercial Operations
Bio & Compensation - Reuters
Joseph H. Smith
Senior Vice President, General Counsel and Secretary
Age: 64
Bio & Compensation - Reuters
Laurie King
Senior Vice President - Human Resources
Age: 55
Bio & Compensation - Reuters
Robert J. Koska
Senior Vice President - Worldwide Commercial Operations
Age: 51
Bio & Compensation - Reuters
Russell K. Enns Ph.D.
Senior Vice President - Regulatory and Clinical Affairs, Quality System and Reimbursement
Age: 60
Bio & Compensation - Reuters